Study of Oxaliplatin and Sorafenib Combination to Treat Gastric Cancer Relapsed After a Cisplatin Based Treatment

Clinical trial NCT01262482 · COMPLETED

Trial details

NCT number: NCT01262482
Sponsor: Grupo Espanol Multidisciplinario del Cancer Digestivo
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (Relapsed After a Cisplatin Based Treatment)

Start date: 2008-10-01
Primary completion: 2011-10-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.